Evidence map›Paper›PMID 40071951›Full record

ArticlemSphere2025

Less reactogenic whole-cell pertussis vaccine confers protection from

Karolína Škopová, Jana Holubová, Barbora Bočková, Eva Slivenecká, João Melo Santos de Barros, Ondřej Staněk, Peter Šebo

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karolína Škopová *Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0009-0004-1645-9286
Jana Holubová *Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0000-0002-0829-0976
Barbora BočkováInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.
Eva SliveneckáInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0009-0002-2391-2080
João Melo Santos de BarrosInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.
Ondřej StaněkInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0000-0003-1575-7834
Peter ŠeboInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0000-0002-9755-7715

Funding

Institute of Microbiology of the Czech Academy of Sciences RVO61388971Ministry of Education Youth and Sports of the Czech Republic Programme EXCELES ID Project No. LX22NPO5103, LM2023053, CZ.02.01.01/00/22_008/0004597Revabiotech SE 2014
6 · The paper itself

Abstract

Pertussis resurged over the last decade in most countries that replaced the traditional whole-cell pertussis vaccines (wP) by the less reactogenic acellular pertussis vaccines (aP). The aP vaccines induce a Th2-polarized immune response and by a yet unknown mechanism hamper the clearance of

Indexed as

Bordetella pertussisPertussis VaccineWhooping CoughAnimalsAntibodies, BacterialAntigens, BacterialFemaleFimbriae ProteinsMiceMice, Inbred BALB CVirulence Factors, BordetellaAntibodies, BacterialAntigens, Bacterialfim2 protein, Bordetellafim3 protein, BordetellaFimbriae ProteinsPertussis VaccineVirulence Factors, BordetellaBordetella pertussisdermonecrotic toxinimmunogenicitylipooligosaccharidepertussis toxinprotectionreactogenicitywhole-cell vaccinewhooping cough

Identifiers

PMID40071951
PMCPMC12039235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.